Analyst Ratings for Merck & Co
Portfolio Pulse from Benzinga Insights
In the last 3 months, 12 analysts have provided 12-month price targets for Merck & Co (NYSE:MRK), with an average target of $127.58. The average price target has increased by 4.68% over the past month.
May 30, 2023 | 7:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merck & Co (NYSE:MRK) has received positive analyst ratings in the last 3 months, with an average 12-month price target of $127.58, up 4.68% in the past month.
The positive analyst ratings and the increase in the average price target over the past month indicate a bullish sentiment towards Merck & Co's stock. This could lead to a short-term increase in the stock price as investors may consider the analysts' opinions when making investment decisions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100